Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial (Q47585646)
scientific article published in May 2004
Language:
Current Data About Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial
(P31) (Q13442814)
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P50) (Q5492406)
(P1545) 4
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(Q792179)
(P1545) 8
(P1932) Axel Haverich
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018

(P304) 2319-2327
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P407) (Q1860)

(P433) 19
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P478) 291
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P577) Saturday, May 1, 2004
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P921) (Q186020)
(P887)

(P1433) (Q1470970)
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P1476) "Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial" (language: en)
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

(P2093) Edward D Verrier
(P1545) 1
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Stanton K Shernan
(P1545) 2
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Kenneth M Taylor
(P1545) 3
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Mark F Newman
(P1545) 5
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

John C Chen
(P1545) 6
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Michel Carrier
(P1545) 7
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Kevin J Malloy
(P1545) 9
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Peter X Adams
(P1545) 10
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Thomas G Todaro
(P1545) 11
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Christopher F Mojcik
(P1545) 12
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Scott A Rollins
(P1545) 13
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

Jerrold H Levy
(P1545) 14
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

PRIMO-CABG Investigators
(P1545) 15
(P248)
(P698) 15150203
(P813) Sunday, February 4, 2018
(P854) http://europepmc.org/abstract/MED/15150203

other details
description scientific article published in May 2004

External Links
(P356) 10.1001/JAMA.291.19.2319
(P698) 15150203
(P5875) 8556461